baber/WOPTO huggingface dataset:
Patent AU-555247-B2 (AU)
Title: Reduced capacitance electrode assembly
Inventor: CANNELLA VINCENT DAVID
IPC: H05H1/46
Filed: 1983-07-25
Granted: 1986-09-18
Abstract: A reduced capacitance electrode assembly for use in an alternating current plasma system provides reduced input capacitance to an associated tuning network. The assembly includes an electrode adapted to receive alternating current power for maintaining a plasma region and a plurality of electrically conductive plates. The plates are closely spaced apart by less than a predetermined distance on one side of the electrode for precluding the formation of a plasma region on the one side of the electrode and for providing a plurality of series capacitances to present a substantially reduced capacitance to the alternating current power. The reduced capacitance electrode assembly is particularly useful in a system for making photovoltaic devices wherein a plurality of amorphous semiconductor materials is deposited onto a continuous conductive substrate moving through a corresponding plurality of deposition chambers. At least one of the chambers includes a reduced capacitance electrode assembly comprising an electrode spaced from the substrate adapted to receive alternating current power for establishing a plasma between the electrode and the substrate, and a plurality of electrically conductive plates being closely spaced apart on the side of the electrode opposite the substrate for confining the plasma between the electrode and the substrate and for providing a plurality of series coupled capacitances to present a substantially reduced capacitance to the alternating current power.
Patent AU-691580-B2 (AU)
Title: Antihyperglycaemic medicament
Inventor: KAAN ELBERT
IPC: C07D403/12
Filed: 1995-04-27
Granted: 1998-05-21
Abstract: The use of 4-chloro-5-((4,5-dihydro-1H-imidazol-2-yl)- amino)-6-methoxypyrimidine of formula (I) or its acid addn. salts is claimed for the prepn. of pharmaceutical compsns. for the treatment of hyperglycaemia. Also claimed in the prepn. of such as compsn. by converting an antihyperglycaemically active amt. of (I) or its salt into a suitable dosage form, in combination with conventional auxiliaries.
Patent AU-753553-B2 (AU)
Title: Enzymatic composition for refining wood
Inventor: HENRY OLIVIER
IPC: C12S3/00
Filed: 1999-12-17
Granted: 2002-10-24
Abstract: The invention relates to an enzymatic composition and also to a method for seasoning wood, intended in particular for applications in the food industry. The method consists in immersing green wood in an aqueous solution comprising an enzymatic composition. The wood can subsequently be dried very rapidly in a drying facility. The invention makes it possible to improve the aromatic characteristics of the wood by eliminating certain substances judged to be undesirable due to their astringent nature or bitter nature, and transforming them into neutrally-tasting molecules.
Patent AU-623858-B2 (AU)
Title: Nitric ester derivative
Inventor: SHIOKAWA YOUICHI
IPC: C07D277/30
Filed: 1988-07-20
Granted: 1992-05-28
Abstract: A compound of the formula : <CHEM> wherein R<1> is hydrogen, lower alkyl, halo(lower)alkyl, halogen, aryl which may have suitable substituent(s), heterocyclic group, amino which may be substituted by suitable substituent(s) or N,N-di(lower)alkylamino(lower)alkyl,  R<2> is hydrogen, lower alkyl or N-[nitrooxy(lower)alkyl]carbamoyl,  X is -O- or -S-,  Y is a single bond, lower alkylene or lower alkenylene, and Z is lower alkylene which may be substituted by suitable substituent(s) or lower alkyleneoxy(lower)alkylene, and pharmaceutically acceptable salts thereof, which have vasodilating activities, to process for the preparation thereof, and to a pharmaceutical composition comprising the same for therapeutical treatment of cardiovascular disorder in human being.
Patent AU-607249-B2 (AU)
Title: Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids
Inventor: FISCHER MEIR
IPC: C12R1/91
Filed: 1988-08-12
Granted: 1991-02-28
Abstract: Plasmids are provided which upon introduction into a suitable Escherichia coli host render the host capable of effecting expression of DNA encoding a desired naturally-occurring polypeptide or polypeptide analog thereof under the control of the deo P1-P2 promoter. Further plasmids are also provided which thermoinducibly direct expression of eucaryotic genes under the control of a  lambda PL promoter and a thermolabile repressor protein present on the same plasmid under the control of a deo P1 promoter. These plasmids have been inserted into various hosts, some of which contain DNA encoding the repressor protein. Such plasmids may be used to produce polypeptides such as human copper/zinc superoxide dismutase, hMnSOD-hGPX fusion polypeptides, human manganese superoxide dismutase, human growth hormone, bovine growth, porcine growth, human growth hormone-apolipoprotein E fused polypeptides, apolipoprotein E and various fibronectin domains.
Patent AU-755196-B2 (AU)
Title: Liner and method for lining a pipeline
Inventor: WOODWARD CLIVE ANTHONY
IPC: F16L55/165
Filed: 1999-03-18
Granted: 2002-12-05
Abstract: The invention relates to a liner comprising a flexible material (1) with means adapted to increase the surface area thereof, and adhesive/sealant (2) and a release tape (3) with reinforcing strips (4). An example of a means of adapting the surface, whereby strips of adhesive/sealant (5) are applied to the release tape and then the flexible material (1) applied and compacted to form the profile. The liner is then formed into a tube. It may be folded into a cruciform shape. An end elevational view of a folded liner in a pipe (6) prior to application of the pipe.
Patent AU-760652-B2 (AU)
Title: Fast slewing pseudorandom noise sequence generator
Inventor: ZOU QUIZHEN
IPC: H03K3/84
Filed: 1999-11-18
Granted: 2003-05-22
Abstract: A novel and improved method and apparatus for a fast-slewing pseudorandom noise sequence generator is described. One or more loadable PN generators are controlled by a DSP or microprocessor in conjunction with a free-running counter which maintains a reference offset count. The PN generator will typically be part of a finger or searcher. The DSP or microprocessor may assist in other finger or searcher functions as well as the slew function, and can control one or more fingers and/or searchers. Each PN generator is comprised of a loadable linear feedback shift register (LFSR) or its equivalent, a loadable counter for maintaining an index of the state of that particular PN generator, and a slew control device capable of receiving a slew command and controlling the LFSR and index counter to enact an advance or a retard of a certain offset distance.
Patent AU-773644-B2 (AU)
Title: Amino group containing support matrices, their use and manufacture
Inventor: FONNUM GEIR
IPC: C08F2/02
Filed: 2000-03-22
Granted: 2004-05-27
Abstract: A method for the manufacture of a support matrix exhibiting amino groups I, possibly in acylated form, comprising the step of polymerising one or more monovinyl monomers (monomer I) with one or more di- tri- or polyvinyl monomers (monomer II). The method is characterized in that that the polymerisation is run in the presence of one or more amino-(C0-10)hydrocarbon vinyl aromatic monomers possibly in acylated form (monomer III. <??>The preferred combination of monomers are ethyl vinyl benzene, divinyl benzene and amino styrene. <??>A support matrix comprising a polyvinyl backbone Ä(-CH2CH2)nÜ and amino groups or groups derived from said amino groups while retaining the nitrogen of the amino group, each of which groups being attached to said backbone via a link structure containing an arylene group. The matrix is charactetized in that each of said groups is directly attached via said nitrogen to said arylene group. <??>The use of the support matrix as defined in any one of claims 1-17, for solid phase synthesis, for instance of an oligo/poly-nucleotide or an oligo/polypeptide.
Patent AU-699311-B2 (AU)
Title: Closure with snap-type hinge cap
Inventor: FUCHS TIMOTHY J
IPC: B65D47/08
Filed: 1995-10-10
Granted: 1998-12-03
Abstract: A closure (10) with a snap type hinge cap comprising a first part (11) adapted to interengage with the open neck of a container, a second part (12) forming a cap and an integral hinge (13) interconnecting the first part (11) and second part (12). Each of the parts (11,12) comprises a base wall (14,20) and a peripheral skirt (15,21). A pair of hinged straps (25) extend from the skirts (15,21) on opposite side of said integral hinge (13). The ends of the straps (25) are substantially straight and lie in substantially the same plane when the first part (11) and second part (12) are in fully open position. Each strap (25) has a portion intermediate the ends which extends out of the plane. Each strap (25) is untensioned when the first part (11) and second part (12) are in fully open position. The intermediate portions of the straps (25) extend axially in one direction. In one form, the intermediate portions of the straps (25) are curved in cross section. In another form, the intermediate portions of the straps (25) are V-shaped in cross section.
Patent AU-660264-B2 (AU)
Title: Shaving aid for a wet razor
Inventor: VREELAND WILLIAM E
IPC: C08L71/02
Filed: 1992-12-16
Granted: 1995-06-15
Abstract: A shaving aid for use with a wet razor comprising a water insoluble polymeric material including at least two different polymers, and a water soluble active ingredient, such as polyethylene oxide. One embodiment of the present invention comprises a flexible, polypropylene razor head, having a shaving aid bonded directly thereto. The shaving aid comprises a water soluble polyethylene oxide and water-insoluble polystyrene and polypropylene. Other additives such as pigments and skin-treating additives are also disclosed. Another embodiment of the present invention comprises the shaving aid molded onto a flexible blade support which is preferably formed of polypropylene.
Patent AU-658266-B2 (AU)
Title: 4-amino-2-ureidopyrimidine-5-carboxamides, a process for the preparation thereof, pharmaceuticals containing these compounds, and the use thereof
Inventor: KAMPE KLAUS-DIETER
IPC: C07D233/30
Filed: 1993-02-19
Granted: 1995-04-06
Abstract: Compounds of the formula I <IMAGE> wherein R<1> to R<5> have the stated meanings, as well as the readily water-soluble salts of these compounds and a process for their preparation. The compounds are suitable for treating lipid metabolism disturbances which are favourably influenced by stimulation of the hepatic LDL-receptor. Compounds of the formula II <IMAGE> and their salts are also described.
Patent AU-572196-B2 (AU)
Title: Production of monomeric human y-interferon
Inventor: NARA KIYOSHI
IPC: A61K38/21
Filed: 1984-10-03
Granted: 1988-05-05
Abstract: Monomeric human -y-interferon is efficiently produced by subjecting crude human γ-interferon to gel filtration under the coexistence of a reducing sulfur compound and a protein-denaturing agent.
Patent AU-671820-B2 (AU)
Title: Non-radioactive DNA sequencing
Inventor: MENDOZA LEOPOLDO G
IPC: C12Q1/6869
Filed: 1993-04-14
Granted: 1996-09-12
Abstract: A new process and kit are described that combines methods for generating the nucleotide base sequence of a DNA molecule with an ultra-sensitive silver staining protocol. This new combination of technologies allows for a direct, non-instrument based visualization of electrophoretically separated sequencing fragments. This non-radioactive system includes sequencing the DNA molecule by forming a set of fragments using an enzymatic dideoxy-mediated chain termination method, electrophoretically separating the DNA fragments on a gel medium, and exposing the gel medium to ultra-sensitive silver-staining solutions for a time determined by viewing the silver stain reacted primer extension products.
Patent AU-637052-B2 (AU)
Title: Macrocyclic polyaza compounds containing 5 or 6 rings, process for producing them and pharmaceutical media containing them
IPC: C07D471/08
Filed: 1989-07-19
Granted: 1993-05-20
Abstract: Macrocyclic compounds of the general formula I <IMAGE>  in which  @is a single or double bond,  q is the numbers 0-5, A and B, which are identical or different, are each a straight-chain or branched alkylene group with 2 to 6 carbon atoms, D is a nitrogen, oxygen atom, the group =C=O, =NR<2> with R<2> being a hydrogen atom or a C1-C6-alkyl group, the group <IMAGE> with R<3> being a hydrogen or halogen atom, a phenyl, a C1-C6-alkyl group which is optionally substituted by one or more phenyl and/or hydroxyl group(s), being the radical OR<5> where R<5> is a C1-C6-alkyl radical which is optionally substituted by 1 to 3 hydroxyl groups, being the substituent <IMAGE> where l is the numbers 0 and 1 and R<6> and R<7> are, independently of one another, hydrogen atoms, the radical R<5>, phenyl or benzyl radicals which are optionally substituted by 1 to 3 hydroxyl groups, or R<6> and R<7> are, together with the nitrogen atom, a saturated or unsaturated, 5- or 6-membered ring which optionally contains another nitrogen, oxygen, sulphur atom or a carbonyl group and which is optionally substituted by 1 to 3 radicals R<5>, or one of the substituents R<6> or R<7> is the radical <IMAGE> or being the substituent G where G is a second macrocycle which is bonded via a direct bond, a bis(carbonylamino) group (-NH-CO-CO-NH-) or via a C1-C20-alkylene group which optionally carries at the ends carbonyl (> CO) or carbonylamino (-NH-CO-) groups or oxygen atoms and optionally contains one or more oxygen atom(s), Z-, acyl- or hydroxyacyl-substituted imino groups or one to two C-C double and/or C-C triple bonds, and has the general formula II <IMAGE> in which D<1> has the same meaning as D with the exception that D<1> does not contain the substituent G, or is the radical -CH-, =C- or -N- and F<1> has the same meaning as F with the exception that F<1> does not contain the substituent G, or is the radical -CH-, or =C-,  E is a nitrogen, sulphur, oxygen atom, the <IMAGE> or >NR<4> group with R<4> being a hydroxyl group, being R<2> or being an optionally hydroxylated or carboxylated C1-C6-alkyl group, F is (-CHR<8>-)n or (=CR<8>)n with n being the numbers 0 or 1 and R<8> being R<1> or G,  R<1> is a hydrogen or halogen atom or a C1-C6-alkyl group, Z is a hydrogen atom or the group -CH2COOY with Y being a hydrogen atom and/or a metal ion equivalent of an element of atomic numbers 21-29, 31, 32, 37-39, 42-44, 49 or 57-83, with the proviso that at least two of the substituents Z are the radical -CH2COOY and that the macrocyclic compound of the general formula I does not contain more than one radical G, and the salts thereof with inorganic and/or organic bases, amino acids or amino amides are valuable diagnostic and therapeutic agents.
Patent AU-696083-B2 (AU)
Title: Caulking gun and cartridge with afterflow prevention
Inventor: VANMOOR ARTHUR
IPC: B65D88/54
Filed: 1995-09-13
Granted: 1998-09-03
Abstract: A caulking gun and cartridge combination is provided with afterflow prevention. The cartridge has a tubular body (8), a forward dispensing opening (9) at a forward end of the tubular body, and a backwall (11, 12) movably disposed within the tubular body (8). The caulking gun has a trough (1) for receiving the cartridge, and a piston (4) movable parallel to the trough (1). A trigger handle (23) is used for pushing the backwall (11) forward within the tubular body and causing a reduction of volume within the chamber (13) in the cartridge. The backwall slides substantially in a contact-less manner within the tubular body, preferebly by way of a reduced diameter (OD) of the backwall (11) relative the inner diameter (ID) of the tubular body (8), so that it is pushed backwardly when the body retracts radially after actuation. Alternatively, the cartridge body may be prevented from expanding or may even be actively squeezed so that afterflow caused by the volume reduction of the relaxing tube body is safely prevented.
Patent AU-594012-B2 (AU)
Title: Novel expression plasmids containing the full cDNA sequence of calf prochymosin
Inventor: BEPPU TERUHIKO
IPC: C12N15/59
Filed: 1985-03-07
Granted: 1990-03-01
Abstract: Expression plasmids containing the full cDNA sequence of calf prochymosin and capable of expressing prochymosin gene in E. coli host cells are disclosed. A method is described for the preparation of said plasmids which comprises altering the spacing between the SD and ATG sequences within the E. coli trp promoter-operator region of the parent expression plasmid, pCR 701, which is known to express prochymosin gene in the E. coli host cells. These modified expression plasmids are designed to provide high expression levels of prochymosin.
Patent AU-741356-B2 (AU)
Title: Aerosol powder valve
Inventor: BAYER CHRISTIAN
IPC: B65D83/16
Filed: 1999-05-20
Granted: 2001-11-29
Abstract: An aerosol powder valve has a valve housing, a valve body with an upstanding valve stem, radial stem orifices, and an annular tight-fitting gasket with a central opening forming the sole seal for the stem orifices. The valve stem is straight-sided above and below the stem orifices and is characterized by the absence of a gasket-receiving groove encircling the stem. The valve body has a plurality of narrow splines spaced around its periphery, the top spline surfaces being of minimal area in relation to the area of the circumferential spaces between the tops of the splines. The spline top surfaces abut the gasket underside when the valve is closed, and the minimal top spline areas prevent powder build-up to adversely affect full sealing of the valve. Other lateral surfaces on the valve body near the gasket are eliminated to likewise avoid powder build-up thereon. The spline sides may diverge outwardly and downwardly from the spline top surfaces. The gasket sealing surface surrounding the valve stem has a lubricant, i.e., silicone, baked thereon. The stem orifices are positioned vertically over circumferential spaces between splines.
Patent AU-756370-B2 (AU)
Title: Myotilin, an actin-organizing protein
Inventor: CARPEN OLLI
IPC: C12N15/12
Filed: 1999-07-14
Granted: 2003-01-09
Abstract: The present invention concerns a novel cytoskeletal protein, myotilin, which contains Ig-like domains homologous to a giant sarcomeric structural protein titin. Myotilin is expressed in skeletal and cardiac muscles, it colocalizes with alpha-actinin in the sarcomeric I-bands and directly interacts with alpha-actinin. Expression of myotilin in mammalian non-muscle cells and in yeast causes reorganization of actin into thick F-actin bundles and inhibits growth of yeast cells.
Patent AU-584160-B2 (AU)
Title: Diisocyanates containing urethane groups, a process for their preparation and their use as binders or binder component in polyurethane lacquers
Inventor: PEDAIN JOSEF
IPC: C07C239/00
Filed: 1986-01-17
Granted: 1989-05-18
Abstract: The present invention is directed to a process for the preparation of a diisocyanate by reacting a diisocyanate with 2,2,4-trimethyl-pentanediol-(1,3) or reaction products of this diol which contain either ether or ester groups and optionally other diols or triols. The present invention is additionally directed to the diisocyanates produced by this process and to their use in one-component and two-component coating compositions.
Patent AU-628568-B2 (AU)
Title: 0 or 3 linked (1,2,4-triazole) and (heteroaryl or indanol) derivatives
Inventor: STEMP GEOFFREY
IPC: C07F9/6558
Filed: 1990-05-22
Granted: 1992-09-17
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof: <CHEM>  wherein either one of R1 and R2 is hydrogen and the other is nitro, cyano, halo, CF3 C2F5, formyl, aldoxime, CF3O, NO2-CH=CH-, NC-CH=CH-; a group RxX-wherein Rx is C1-6 alkyl, aryl or heteroaryl either of which may be optionally substituted by one, two or three of C1-4 alkyl, C1-4 alkoxy, nitro, halo, CF3 and cyano; and x is C=O, O.C=O, C=O.O, CHOH, SO, SO2, O.SO, O.SO2, CONH, O.CONH, C=S, O.C=S, C=S.O, CH.SH, SONH, SO2NH, O.SONH, O.SO2NH, CO-CH=CH, C=NHOH, C=NNH2; or a group RyRzNZ- wherein Ry and Rz are independently hydrogen or C1-6 alkyl and Z is C=O, SO or SO2; or a group (RwO)2P(O)W wherein Rw is hydrogen or C1-6 alkyl and W is O or a bond; or R1 is a C3-8 cycloalkyl group or a C1-6 alkyl group optionally substituted by a group which is hydroxy, C1-6 alkoxy, amino optionally substituted by one or two C1-6 alkyl groups, C1-7 alkanoylamino, C3-8 cycloalkyloxy or C3-8 cycloalkylamino; and R2 is hydrogen; or one of R1 and R2 is nitro, cyano or C1-3 alkylcarbonyl and the other is a different group selected from nitro, cyano, halo, C1-3 alkylcarbonyl, methoxy or amino optionally substituted by one or two C1-6 alkyl or by C2-7 alkanoyl; or R1 and R2 together with the carbon atoms to which they are attached, form 2,1,3-oxadiazole; either one of R3 and R4 is hydrogen or C1-4 alkyl and the other is C1-4 alkyl; or  R3 and R4 together are C2-5 polymethylene;  R5 is hydrogen, hydroxy, C1-6 alkoxy or C1-7 acyloxy; and  R6 is hydrogen; or  R5 and R6 together form a bond; R7 is C1-6 alkyl or phenyl C1-4 alkyl optionally substituted in the phenyl ring by up to three moieties selected from C1-4 alkyl, C1-4 alkoxy or halo; and  R8 is amino, hydrogen or methyl; which are potassium channel activators, a process for their preparation and their pharmaceutical use.
Patent AU-704269-B2 (AU)
Title: Process and plant for the treatment of waste containing asbestos
Inventor: DEBAILLEUL GERARD
IPC: A62D101/41
Filed: 1996-06-10
Granted: 1999-04-15
Abstract: A method for processing asbestos-containing waste from a waste generating site, wherein the waste is transferred from the site to a processing reactor without exposing the waste to an external environment, a basic reaction solution is fed into the reactor, a reaction is carried out to give a substantially fiber-free reaction product, and the reaction product is separated into a solid phase and a liquid phase. The separated liquid phase is optionally recycled to form the basic reaction solution and the separated solid phase is optionally recovered to enable upgrading thereof.
Patent AU-769517-B2 (AU)
Title: Neutral lipopolymer and liposomal compositions containing same
Inventor: ZALIPSKY SAMUEL
IPC: A61K47/42
Filed: 2000-07-12
Granted: 2004-01-29
Abstract: Liposomes containing PEG-substituted neutral lipopolymers provide similar circulation times to liposomes incorporating conventional, negatively charged PEG-substituted phospholipids. Use of the uncharged lipopolymers can also present advantages in terms of interactions with cell surfaces and reduced leakage of charged substances, particularly cationic drugs, from the liposomes. The lipopolymers are of the formula:wherein each of R1 and R2 is an alkyl or alkenyl chain having between about 8 to about 24 carbon atoms, n is about 10 to about 300, Z is selected from the group consisting of hydroxy, alkoxy, benzyloxy, carboxylic ester, sulfonic ester, alkyl or aryl carbonate, amino, and alkylamino, and the linkage L is selected from the group consisting of (i) -X-(C=O)-Y-CH2-, (ii) -X-(C=O)-, and (iii) -X-CH2-, wherein X and Y are independently selected from oxygen, NH, and a direct linkage.